Shares of Krishna Institute of Medical Sciences Limited (KIMS) gained 3% following the announcement of its Q2 FY25 financial results, which reflected strong growth in revenue and profits. The company’s net income reached ₹1,074 million, marking an increase from ₹920 million in the same quarter last year, as KIMS continues to demonstrate robust financial health.
Key Financial Highlights for Q2 FY25
- Sales: ₹7,773 million, up from ₹6,525 million in Q2 FY24.
- Revenue: ₹7,823 million, compared to ₹6,554 million last year.
- Net Income: ₹1,074 million, showing an increase from ₹920 million in Q2 FY24.
- Earnings per Share:
- Basic and Diluted EPS from continuing operations stood at ₹2.68, up from ₹2.3 a year ago.
First Half of FY25 Highlights
- Sales: ₹14,657 million, an improvement from ₹12,585 million in the same period last year.
- Revenue: ₹14,753 million, up from ₹12,645 million.
- Net Income: ₹1,940 million, rising from ₹1,728 million YoY.
- EPS: Basic and diluted EPS from continuing operations was ₹4.85, up from ₹4.32.
As of 9:22 am, KIMS shares were trading 1.95% higher at ₹581.25 on the NSE.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
